Nu Skin Enterprises Inc (NUS)

Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child NutritionMay 15, 2026 7:00 AM
Business Wire The company’s Nourish the Children initiative feeds about 75,000 children each day Nu Skin Enterprises, Inc. (NYSE: NUS), a global leader in beauty and wellness, today announced it has reached the milestone of providing 900 million meals for children since 2002 through its Nourish the Children initiative. Malnourished children in more than 65 countries around the world have been fed VitaMeal,* a nutrient-dense food, from one of the company’s third-party charity partners after Nu Skin sales leaders, customers or employees purchase and donate bags of food. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260515344503/en/Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child Nutrition “It is amazing to think of 900 million meals when you imagine the difference we have made in the lives of so many children around the world,” said Ryan Napierski, Nu Skin president and CEO. “And we’re not done – we continue to feed 75,000 children each day as we set our sights on 1 billion meals. As we look to the future, we’re committed to building on this momentum by leveraging our innovation and global community to nourish not only children, but to help people everywhere look, feel and live better.” About VitaMeal Unlike simple grains with a mostly caloric benefit, VitaMeal is a nutrient-dense food scientifically formulated to meet the nutritional needs of malnourished children. As part of the overall development of VitaMeal, Nu Skin's nutritional scientists determined the ingredients and ratios that are well suited for a malnourished child. The result is a product that provides essential vitamins and minerals, with a balance of carbohydrates, protein, fat and fiber. About Nourish the Children In 2002, Nu Skin took action to address the tragedy of childhood hunger and malnutrition with the development of the Nourish the Children initiative with a highly nutritious food known as VitaMeal, developed by Nu Skin's nutritional scientists. The company's sales leaders, customers and employees can purchase VitaMeal and designate it for donation to a third-party nonprofit organization that specializes in distributing relief to those suffering from malnutrition and famine. About Nu Skin Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with its newly introduced Prysm iO intelligent wellness platform, an award-winning line of beauty device systems and trusted brands in personal care and wellness products. Rhyz is the strategic investment arm of Nu Skin Enterprises, formed in 2018 consisting of synergistic consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories. *Nu Skin is a for-profit distributor of nutritional and skin care products and is traded on the New York Stock Exchange (NUS). Nourish the Children is an initiative of Nu Skin and is registered in some states as a commercial co-venture. The initiative enables Nu Skin’s Brand Affiliates and customers to purchase VitaMeal from Nu Skin and donate it to charitable organizations to help solve the complex world problem of feeding malnourished children. The price of VitaMeal includes the cost of manufacturing, general overhead, distribution and sales. As is the case with other Nu Skin products, Brand Affiliates are paid commissions and Nu Skin earns a profit margin from each sale of VitaMeal. View source version on businesswire.com: https://www.businesswire.com/news/home/20260515344503/en/ Media:

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 1Q26May 8, 2026 1:34 PM
NewsfileDallas, Texas--(Newsfile Corp. - May 8, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj NI, and adj EPS of $320.6M, $6.8M, and $0.14, respectively. This compares to our estimates of $329.7M, $7.7M, and $0.15, respectively. Revenue came in near the low end of guidance, while adjusted EPS remained within range as management continued investing behind Prysm iO and emerging markets while maintaining cost discipline. Core Nu Skin gross margin improved 20 bps y/y to 76.9%, while adjusted operating margin was 3.6% versus 6.4% last year. The more important takeaway was management's commentary that brand affiliate confidence improved and new sales leaders grew y/y exiting the quarter, suggesting early field stabilization as Prysm iO training and leader engagement scale. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Prysm iO remains the core commercialization catalyst. Nearly 2M scans across 30,000+ devices supports early adoption, while 5% y/y subscription volume growth suggests the platform is beginning to improve customer engagement and recurring revenue quality. Field trends are showing early stabilization despite pressured headline KPIs. Sales leaders, paid affiliates, and customers declined 13%, 8%, and 14% y/y, respectively, but management cited improving brand affiliate confidence and y/y growth in new sales leaders exiting the quarter. Guidance implies confidence in a 2H26 improvement cadence. NUS maintained FY26 revenue and adjusted EPS guidance of $1.35B-$1.50B and $0.80-$1.20, supported by broader Prysm iO adoption, India's planned year-end launch, and continued cost discipline. Click image above to view full announcement. About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies. Contacts: Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com Source: Stonegate, Inc. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/296705 Original: Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 1Q26

Nu Skin Enterprises to Announce First Quarter 2026 Financial ResultsApril 13, 2026 4:05 PM
Business Wire
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2026 results after the market closes on Thursday, May 7. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives.


The webcast of the conference call, including the financial information presented, will be available on the investor relations page of the company’s website at ir.nuskin.com. A replay of the webcast will be available at the same location through Thursday, May 21.


About Nu Skin Enterprises Inc.


The Nu Skin Enterprises Inc. (NYSE: NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, which includes an award-winning line of beauty and wellness device systems. Formed in 2018, Rhyz is a synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260413223734/en/
Media:

Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional WellnessApril 2, 2026 4:25 PM
Business Wire
Breakthrough intelligent platform measures skin carotenoid levels for antioxidant insights in just 15 seconds, empowering consumers to take control of their nutritional wellness


Nu Skin Enterprises Inc. (NYSE: NUS), the world's #1 company for beauty and wellness device systems,* today announced the general consumer availability in the U.S. of Prysm iO™, a breakthrough intelligent nutritional wellness platform designed to deliver a better understanding of how daily nutrition and supplement routines support overall wellness. Prysm iO will launch for consumers in other Nu Skin markets in the coming months.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402013607/en/The Prysm iO intelligent wellness platform from Nu Skin is now available.
Compact, portable and powered by advanced AI, Prysm iO gives users science-backed insight in seconds, helping remove the guesswork from wellness. The small, circular device uses advanced skin-scanning technology to noninvasively scan the fingertip and deliver a personalized reading in just 15 seconds. The device measures carotenoids, powerful antioxidants that support immune health, heart and brain health, radiant skin, and cellular health. The result is a clearer picture of antioxidant status and nutrient uptake without lab visits or complicated testing, empowering users to make more informed choices about their wellness routines.


"Prysm iO represents a new frontier for personalized wellness and another critical milestone in our vision to become the world’s leading intelligent beauty and wellness company, powered by our dynamic affiliate opportunity platform," said Ryan Napierski, president and CEO of Nu Skin. "We've brought together decades of nutritional research and cutting-edge AI to give consumers clearer, more personalized answers about their health than ever before. We're incredibly proud to make that level of insight simple, accessible and actionable for everyone."


Grounded in 20+ Years of Carotenoid Science


Prysm iO is built on more than two decades of carotenoid research and innovation. The device incorporates patent-pending Spectral Rai Technology, capturing more than 700,000 hyperspectral absorption measurements during each scan. A proprietary AI-powered algorithm referencing proven Spectral Rai technology then translates that complex data into a personalized “Nutrition Health Score.” Nu Skin’s platform is further strengthened by a database of more than 20 million antioxidant scans, making Prysm iO one of the most advanced and robust systems of its kind.


Actionable Insights That Empower Wellness Goals


With each scan, users receive their Prysm Score along with tailored feedback to help them better understand how their current nutrition and supplement routine is supporting their antioxidant levels. Used regularly, Prysm iO enables users to see where they are today, track progress over time and make informed, meaningful adjustments to their wellness routines.


Prysm iO integrates seamlessly with Nu Skin's broader wellness ecosystem, including Prysm-certified supplements such as LifePak®, MYND360™ Mind Full, Beauty Focus® Collagen+, ageLOC® Youth, Pharmanex® Eye Formula and G3®.


“People today are more invested in their health than ever before, but for too long, wellness decisions have been based on guesswork,” said Dr. Joe Chang, chair of the Nu Skin Scientific Advisory Board. “Prysm iO changes that by giving everyday consumers access to precise, personalized nutritional insights and a clearer understanding of whether their daily choices are making a meaningful difference. It offers a science-backed way to make wellness decisions with greater confidence and build a more informed relationship with their health.”


Clinically Tested for Precision and Impact


Nu Skin's commitment to scientific rigor is at the heart of Prysm iO. Several studies have been completed or are in progress, including the recent publication of clinical validation data demonstrating that the Prysm iO intelligent wellness device delivers reliable, science-backed insight into antioxidant levels through a simple 15-second skin scan instead of an invasive blood draw.


Led by renowned clinical and research dermatologist Dr. Zoe Draelos, MD, FAAD, the study published in Food and Nutrition Journal evaluated 97 participants across diverse demographics and skin types. Results showed Prysm iO measurements achieved strong correlation with blood serum levels (R² = 0.75-0.77), matching performance benchmarks of established optical measurement technologies while delivering superior accessibility and convenience.


Highlights from the study include:



Strong correlation between Prysm iO skin measurements and blood carotenoid levels



Consistent accuracy across diverse skin types



Reproducible results across multiple devices demonstrating manufacturing precision



Availability


The Nu Skin Prysm iO is now available in the U.S. for $375. For more information, visit nuskin.com.


About Nu Skin Enterprises Inc.


The Nu Skin Enterprises Inc. (NYSE: NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, which includes an award-winning line of beauty and wellness device systems. Formed in 2018, Rhyz is a synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.


*Source: Euromonitor International Limited: At-Home Beauty and Wellness Device Systems on a total retail level in RSP, excluding salon services that may offer packages; research conducted May–July 2025.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260402013607/en/
Media:

Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial OfficerMarch 20, 2026 4:05 PM
Business Wire
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of Chelsea Lantz as interim Chief Financial Officer, effective immediately. The appointment of Lantz comes after James Thomas stepped down as CFO to pursue an outside opportunity.


“On behalf of our board, management and the entire Nu Skin team, we thank James for his leadership and significant contributions over 16 years at Nu Skin and wish him and his family well in their future pursuits,” said Ryan Napierski, president and CEO. “We have a talented finance team who has led the ongoing work to improve our operational performance and strengthen our balance sheet over the past year. I am excited to work directly with Chelsea to carry forward this important work as we further our transformation to becoming the world’s leading intelligent beauty and wellness leadership opportunity platform.”


Nu Skin’s board of directors has appointed Lantz as interim CFO and has initiated a formal process to appoint a permanent replacement. Lantz joined Nu Skin in 2011 and has worked as corporate controller since 2023, leading the company’s cost-improvement efforts, which resulted in a significant increase in EPS year-over-year. Lantz came to Nu Skin from PricewaterhouseCoopers LLP where she led financial audits and internal controls for public and private companies. She holds a Master of Accounting degree from Utah State University and a bachelor’s degree from Westminster University.


About Nu Skin Enterprises, Inc.


Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with our newly introduced Prysm iO intelligent wellness platform, an award-winning line of beauty device systems and trusted brands in personal care and wellness products. Rhyz is the strategic investment arm of Nu Skin Enterprises, formed in 2018 consisting of synergistic consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260320500689/en/
Media:

Nu Skin Appoints Chayce Clark as COOMarch 9, 2026 4:05 PM
Business Wire
Clark to expand on his responsibilities as chief legal officer to oversee company operational functions and revenue performance


Nu Skin Enterprises Inc. (NYSE:NUS) today announced the appointment of Chayce Clark as chief operating officer effective immediately. Clark will be responsible for leading the company’s revenue performance and end-to-end operational execution across the business in addition to maintaining his role as the company’s chief legal officer.


“Chayce has been a valuable part of our executive team and an important voice in our efforts to become the world’s leading intelligent beauty and wellness leadership opportunity platform,” said Ryan Napierski, president and CEO. “We are expanding his responsibilities to establish a more dedicated role to maximize the work of our global operational teams. Our goal is to build a more integrated global organization where our teams are empowered by greater clarity, supported by disciplined execution and aligned around measurable outcomes.”


In this role, Chayce will oversee the global sales channel, product innovation, technology platforms, global programs, brand initiatives and legal services as part of a global operations team. This team will work together to drive greater collaboration, alignment and efficiencies across the nearly 50 markets in which Nu Skin operates.


“We have strong growth opportunities ahead of us at Nu Skin with the rollout of our Prysm iO intelligent wellness platform and our expansion into India as part of our emerging market strategy,” said Clark, executive vice president, COO and CLO. “We can maximize these opportunities by building greater global alignment around our products, technology and go-to-market plans to sharpen our execution of our enterprise strategies.”


Clark joined Nu Skin in 2015 as assistant general counsel and later served as vice president and deputy general counsel before beginning his role as general counsel. Prior to Nu Skin, Clark was a litigation attorney in private practice in Salt Lake City. He received a bachelor’s degree from Southern Utah University and a J.D. degree from the University of Utah.


About Nu Skin


Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with our newly introduced Prysm iO intelligent wellness platform, an award-winning line of beauty device systems and trusted brands in personal care and wellness products. Rhyz is the strategic investment arm of Nu Skin Enterprises, formed in 2018 consisting of synergistic consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260309079173/en/
Media:

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2025 Q4February 13, 2026 9:43 AM
NewsfileDallas, Texas--(Newsfile Corp. - February 13, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj NI, and adj EPS of $370.3M, $14.5M, and $0.29, respectively. This compares to our estimates of $380.2M, $15.1M, and $0.30, respectively. These results were at the low end of revenue guidance and the high end of EPS guidance. Rhyz delivered $48.52M of revenue, including $42.45M from Manufacturing and $6.07M from Rhyz Other, while the Nu Skin business posted 77.6% gross margin and continued to benefit from disciplined spending as selling expense declined to 40.8% of the core business. Management highlighted strategic and active penetration into India and other emerging countries, along with overall margin expansion and a one-time tax benefit, as key contributors to EPS results in FY25. Despite weaker-than-expected top-line results, management remains focused on executing its strategic initiatives. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Prism iO rollout advancing in 1H26 India pre-launch underway; full opening expected 2H26 FY26 EPS Guidance midpoint of a $1.00 Click image above to view full announcement. About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies. Contacts: Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com Source: Stonegate, Inc. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283830
Original: Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2025 Q4

Nu Skin Enterprises Announces Quarterly DividendFebruary 12, 2026 4:05 PM
Business Wire
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has declared a quarterly cash dividend of $0.06 per share, which will be paid on Mar. 11, 2026, to shareholders of record on Feb. 27, 2026.


About Nu Skin Enterprises Inc.


Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with our newly introduced Prysm iO intelligent wellness platform, an award-winning line of beauty device systems and trusted brands in personal care and wellness products. Rhyz is the strategic investment arm of Nu Skin Enterprises, formed in 2018 consisting of synergistic consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260212189743/en/
Media:

Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular WellnessFebruary 6, 2026 1:56 PM
Business Wire
The updated edition of the New York Times bestseller from the chair of the Nu Skin Scientific Advisory Board reveals latest science behind measurable biology and evidence-based longevity


Nu Skin Enterprises Inc. (NYSE: NUS) today announced the relaunch of “The Aging Myth: Unlocking the Mysteries of Looking and Feeling Young,” the updated edition of the bestselling book from Dr. Joseph Chang, chair of Nu Skin’s Scientific Advisory Board. The relaunch marks a significant milestone in the evolution of evidence-based beauty and wellness, bringing together decades of research that underpin Nu Skin’s science-led innovations — from ageLOC® technology to the company’s intelligent beauty and wellness platform centered on Prysm iO™.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260206515806/en/Dr. Joseph Chang of Nu Skin with his relaunched bestselling book, The Aging Myth. Many of the discoveries in his new book were instrumental in the development of the Prysm iO intelligent wellness platform.
Originally published in 2011, "The Aging Myth" challenged conventional wisdom by proving that aging isn't about genetic destiny, but about how our genes function. It helps readers understand the science behind their healthspan, or the number of healthy years they live. As people live longer, the concept of wellness is becoming focused on the quality of health during those years. The book quickly became a hit, reaching #2 on The New York Times Best Seller List in its first week and securing the #1 spot at Barnes & Noble, and top rankings on Amazon, Borders and The Wall Street Journal best seller lists.


"The fundamental premise remains unchanged: we are not prisoners of our genetics," said Dr. Chang. "However, the science of aging has evolved tremendously since 2011. This updated edition reflects over 15 years of additional research that continues to validate our core message: aging is biology in motion, and biology can be influenced. When wellness becomes measurable, it transforms from rhetoric into science."


The new edition builds on the original by featuring expanded chapters on cellular resilience, oxidative stress management and the role of measurable biomarkers in health optimization. The updated content addresses how modern technology enables individuals to move beyond subjective feelings about health to objective, measurable insights about their biological age and cellular function. Dr. Chang draws from his experience guiding Nu Skin's quarter-century commitment to evidence-driven wellness research, including breakthrough technologies like the Prysm iO intelligent wellness platform, a non-invasive skin carotenoid measurement device, which provides intelligent insights into an individual’s nutritional health.


"For years, Dr. Chang’s work has guided Nu Skin’s commitment to evidence-based innovation," said Ryan Napierski, president and CEO. "What makes this relaunch so timely is how closely the research aligns with where Nu Skin is today as we work toward our vision to become the world’s leading intelligent beauty and wellness platform. This updated edition shows how the concepts introduced more than a decade ago have matured into a fully realized ecosystem — one where intelligent devices, targeted nutrition and personalized insights work together to support healthier aging. We believe this book provides the scientific foundation for the next decade of intelligent beauty and wellness.”


The digital edition of "The Aging Myth" is available through Amazon Kindle and other major online book retailers beginning today for $9.99.


About The Author


Joseph Y. Chang, Ph.D., was appointed chair of the Nu Skin Scientific Advisory Board in 2024. Prior to that, he served as Nu Skin's chief scientific officer and executive vice president of product development for 18 years. A prolific author, Dr. Chang has published numerous articles, reviews and books on pharmacological research, including the New York Times best seller, The Aging Myth. With over 35 years of experience in the pharmaceutical and dietary supplement industries, Joe enjoys a comprehensive knowledge of both industries. Prior to the acquisition of Pharmanex by Nu Skin Enterprises in 1998, he served as the vice president of clinical studies and pharmacology at Pharmanex.


He has also held various research management positions at Wyeth-Ayerst, Rhone Poulenc Rorer and other biotechnology companies, where he was involved in researching natural products for arthritis and immunosuppressive treatment. He received a B.S. degree from Portsmouth University and a Ph.D. from the University of London.


About Nu Skin Enterprises Inc.


The Nu Skin Enterprises Inc. (NYSE: NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, which includes an award-winning line of beauty and wellness device systems. Formed in 2018, Rhyz is a synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260206515806/en/
Media:

Beginning to do better. Excited about the upcoming ER

Nice rebounding. Still on the sidelines though.

No posts for years here. Fell below $10 for the first time in Years. Value territory?

Has moved up nicely since March.

.. does it keep going, and if so whats the catalyst.

Company has crazy history.

32ish buy buy buy

Sidoti upgraded NUS to Buy today. Shares may have 17% upside:

Fair Value Analysis

NUS SEC Admin Proceeding:

https://www.sec.gov/litigation/admin/2016/34-78884.pdf

Harry has posted Charts of the Day video on NUS at TheTechTrader site noting: Nu Skin Enterprises Inc. (NUS) had a big breakout on Thursday, up 4.21 to 44.90, or 10%, on 3 million shares. A big declining topsline was broken recently, and the inverse neckline was broken on Thursday. Perhaps we’re going to see a test of 49.90-50 coming up.

Bad report - goes up. Good report - goes down. Go figure.

P.s. still think $14 are not out of the question here...

Decent volume today. Around 40% up since lows of last month.

Closed the gap. Going back down to sub-25?

Bouncing right back up.

Thanks bro.

Crappy annual report. Missed on all levels -- revenue, YoY, QoQ etc.
Bad guidance too.

However, I do see couple of positives:
1. They repurchased about 5% of O/S last year and probably will continue
2. Number of so-called 'sales leaders' increased slightly, or at least stopped dropping. Sales leaders generate majority of sales through their groups (they have a $2000-3000 requirement) which points to an increased revenues. Not immediately, but eventually.


I do plan on buying if this dips below $20

Why this tock go down today bro? Thanks

Holy moly!
I guess my prediction of $14/share can come true in the next couple of months...

you still hanging onto your $33's?

Just got an email from Nuskin
Beginning November 1st, pricing for both online and ADR shipping will decrease for orders up to $50. Shipping will remain FREE for orders over $500.

It's about time. Last couple emails on the subject I received were price hikes. Even though gas prices have dropped significantly!
Maybe now good carma will be on your side

At today's close of $37+ your entry looks impeccable. Congrats.
I am, however, looking forward to see the number of sales leaders in the latest ER. If the number dropped from last Q, you know that this quarter's sales will drop too. It's as simple as that.

Got in at 33 what ya think

Back to low 40's... my price target of 14 still stands. I expect revenues to keep dropping because numbers of sales leaders keeps shrinking...

Two days in a row dipping below $50...

NUS, you gotta make up your mind -- either go up or down

Slowly crawling back, trying to survive...

Of course the revenue is very disappointing. After hours volume is ~115K, some of them are large blocks of 1000+shares

Number of 'active distributors' and 'sales leaders' dropped yet again -- that tells you next Q revenue will most likely be even lower

Dividend of 35c at $60 was 2.3% annualized
At $50 it's 2.8% which is actually pretty nice

Sweet bananas, this IS a disappointing quarter!

MASSIVE after-hours $NUS sell-off on earnings disappointment.

ER on Wednesday. The question is whether dollar strength in Q1 hurt Nuskin more than they'd like?

I have a dilemma. I want to buy NuSkin. But I want to buy it below $20/share ;)

Maybe, but FVRG would certainly add to NUS product-line and balance.

Just released today: ForeverGreen Worldwide Corp. Reports 229% Increase in 2014 Revenues to $58.3 Million; Gross Profit Increased 253% to $45.9 Mi...anticipated 50%+ sales growth during 2015 and 2016”

They keep growing...

Big range today.

They have done couple acquisitions historically but looks like they prefer organic growth.

I wonder whether NuSkin might be interested in acquiring this soaring MLM? Forevergreen (FVRG): It fits the bill, healthy products and profit-wise. 90-100 million revenue per year expected, an increase of 45% over the previous year's expected growth, and 12 months of consecutive MoM triple digit revenue growth. Pretty impressive!

Who doesn't like a healthy law suit? lol

it is just hedgies selling ghost shares.

wow, another big jump that doesn't make sense. Q4 report was good, but not $50 good....

The chart is waltzing: up, up, Down! Up up Down!

3 months chart looks like a "maybe". 1 year chart says "stay away"....

Nu Skin Enterprises, Inc. will release fourth-quarter and full-year 2014 results prior to the market opening on Thursday, Feb. 5.

Market estimates $600M revenue for Q4. 2013 Q4 was $1 Billion. Doesn't look very promising for PPS

Three months chart looks like disaster. If it breaks 38 support its going to get ugly